Literature DB >> 1517242

Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells.

N Shimbara1, E Orino, S Sone, T Ogura, M Takashina, M Shono, T Tamura, H Yasuda, K Tanaka, A Ichihara.   

Abstract

We have reported that proteasomes are expressed at abnormally high levels in various hematopoietic tumor cells (Kumatori, A., Tanaka, K., Inamura, N., Sone, S., Ogura, T., Matsumoto, T., Tachikawa, T., Shin, S., and Ichihara, A. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 7071-7075). In the present study, we examined changes in the expressions of proteasomes during growth of peripheral T-lymphocytes from healthy adults and differentiation of human leukemic cell lines. Up-regulation of mRNAs encoding multiple proteasome subunits was observed during proliferation of resting T-cells induced by mitogens such as phytohemagglutinin and interleukin-2. In contrast, in vitro terminal differentiation into monocytic, granulocytic, and erythroid cells of various immature leukemic cell lines, such as HL-60 promyelocytic leukemia cells and K562 erythroleukemia cells, by various inducing agents caused rapid and marked down-regulation of proteasomes expression, independently of the cell type, direction of differentiation, or type of signal. The syntheses of proteasome subunits of 21-31 kDa and their associated components of 35-110 kDa, measured by [35S]methionine incorporation, were much higher in mitogen-activated T-cells and unstimulated HL-60 cells, which grow rapidly, than in resting and differentiated cells, indicating apparent correlations of the mRNA levels of proteasomes with their translational activities. However, immunochemically, no detectable difference in the cellular contents of proteasomes was found in these cells in induced and uninduced states for proliferation and differentiation, suggesting accelerated turnover of proteasomes in rapidly proliferating cells. Inhibition of proteasome expression by an antisense oligodeoxynucleotide for the largest proteasome subunit, C2, caused partial arrest of cell cycle progression of T-lymphocytes, suggesting that up-regulation of proteasomes is indispensable for proliferation of the cells. We also observed that the nuclear fraction of proteasomes increased in proliferating T-cells and that proteasomes moved rapidly between the nucleus and cytoplasm during differentiation of HL-60 cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517242

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Prosomes (proteasomes) changes during differentiation are related to the type of inducer.

Authors:  J P Bureau; L Henry; A Baz; K Scherrer; M T Château
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

Review 2.  Proteasomes: multicatalytic proteinase complexes.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

Review 3.  Roles of proteasomes in cell growth.

Authors:  A Ichihara; K Tanaka
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

4.  Ubiquitin and ubiquitin-protein conjugates in PC12h cells: changes during neuronal differentiation.

Authors:  K Takada; T Kanda; K Ohkawa; M Matsuda
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

5.  Alterations of proteasome activities in skeletal muscle tissue of diabetic rats.

Authors:  S Merforth; A Osmers; B Dahlmann
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

6.  Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway.

Authors:  A Mathew; S K Mathur; R I Morimoto
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes.

Authors:  W E Mitch; R Medina; S Grieber; R C May; B K England; S R Price; J L Bailey; A L Goldberg
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Morphologic, immunologic, biochemical, and cytogenetic characteristics of the human glioblastoma-derived cell line, SNB-19.

Authors:  W C Welch; R S Morrison; J L Gross; S M Gollin; R B Kitson; R H Goldfarb; K A Giuliano; M K Bradley; P L Kornblith
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

9.  Concomitant differentiation and partial proteasome inhibition trigger apoptosis in neuroblastoma cells.

Authors:  Piruz Nahreini; Cynthia Andreatta; Amy Hanson; Kedar N Prasad
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.

Authors:  M C C Gomes-Marcondes; H J Smith; J C Cooper; M J Tisdale
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.